# OnCo record kan-004 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/kan-004/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "kan-004" ;
  schema:name "KAN-004"@en ;
  schema:description "KAN-004 is an experimental live biotherapeutic product from Kanvas Biosciences, in phase 1 trials for immune checkpoint inhibitor-induced colitis in people with solid tumours."@en ;
  schema:url <https://onco.cc/drugs/kan-004/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.kanvasbio.com/news/kan004-fpi>, <https://www.kanvasbio.com/news/kan004-fpi>, <https://clinicaltrials.gov/api/v2/studies/NCT07196410>, <https://clinicaltrials.gov/search?intr=KAN-004> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Live biotherapeutic product (oral capsule, consortium of more than 100 microbial strains)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/kanvas-biosciences/> ;
  onco:trials <https://onco.cc/trials/nct07196410/> .